- Home
- BANC vs TNGX Comparison
BANC vs TNGX Comparison
Compare BANC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANC | TNGX |
|---|---|---|
| Founded | 1941 | 2014 |
| Country | United States | United States |
| Employees | 1903 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.8B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BANC | TNGX |
|---|---|---|
| Price | $18.56 | $19.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $20.60 | $20.00 |
| AVG Volume (30 Days) | ★ 3.0M | 2.7M |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | ★ 26.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $62,384,000.00 |
| Revenue This Year | $13.45 | N/A |
| Revenue Next Year | $7.98 | N/A |
| P/E Ratio | $17.08 | ★ N/A |
| Revenue Growth | N/A | ★ 48.29 |
| 52 Week Low | $11.70 | $1.04 |
| 52 Week High | $21.61 | $22.20 |
Technical Indicators
Market Signals| Indicator | BANC | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 62.01 | 59.39 |
| Support Level | $16.30 | $6.54 |
| Resistance Level | $21.43 | $21.82 |
| Average True Range (ATR) | 0.41 | 1.25 |
| MACD | 0.25 | -0.20 |
| Stochastic Oscillator | 89.27 | 34.49 |
Price Performance
Historical ComparisonAbout BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.